General
Preferred name
Dicoumarol
Synonyms
DICUMAROL ()
4-hydroxy-3-[(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]-2H-chromen-2-one ()
NSC-41834 ()
NSC-221570 ()
NSC-17860 ()
Bishydroxycoumarin ()
Dicoumarolum ()
P&D ID
PD002380
CAS
66-76-2
Tags
available
drug
Approved by
FDA
First approval
1944
Drug indication
Recurrent thrombophlebitis
Bleeding disorder
Thrombosis
Drug Status
approved
withdrawn
Max Phase
4.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Vitamin K epoxide reductase complex subunit 1 isoform 1 inhibitor (GtoPdb)
PHARMACODYNAMICS Dicumarol is an coumarin-like compound found in sweet clover. It is used as an oral anticoagulant and acts by inhibiting the hepatic synthesis of vitamin K-dependent coagulation factors (prothrombin and factors VII, IX, and X).
PRICE 29
DESCRIPTION Dicoumarol (Dicumarol) is a hydroxycoumarin originally isolated from molding sweet-clover hay, with anticoagulant and vitamin K depletion activities. Dicoumarol is a competitive inhibitor of vitamin K epoxidereductase; thus, it inhibits vitamin K recycling and causes depletion of active vitamin K in blood. This prevents the formation of the active form of prothrombin and several other coagulant enzymes, and inhibits blood clotting.
DESCRIPTION Dicumarol inhibits vitamin K reductase. It is used for decreasing blood clotting. (Enamine Bioactive Compounds)
DESCRIPTION Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis; Inhibition of human recombinant NQO1 (TargetMol Bioactive Compound Library)
Cell lines
2
Organisms
1
Compound Sets
27
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine Bioactive Compounds
Enamine BioReference Compounds
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
Withdrawn 2.0
ZINC Tool Compounds
External IDs
67
Properties
(calculated by RDKit )
Molecular Weight
336.06
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
2
Rotatable Bonds
2
Ring Count
4
Aromatic Ring Count
4
cLogP
2.9
TPSA
100.88
Fraction CSP3
0.05
Chiral centers
0.0
Largest ring
6.0
QED
0.55
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Member status
member
MOA
NADPH Quinone Oxidoreductase 1 (NQO1) Inhibitors
Anticoagulant
Vitamin K Epoxide Reductase (VKER, VKOR) Inhibitors
NADPH inhibitor
Target
CRYZ, NQO1, VKORC1
PDHK
Quinone Reductase
Indication
deep vein thrombosis (DVT)
ATC
B01AA01
Therapeutic Class
Anticoagulants
Pathway
Metabolic Enzyme/Protease
Source data